Dieser Anti-SARS-CoV-2 Nucleocapsid-Antikörper ist ein Human-Monoklonal-Antikörper zum Nachweis von SARS-CoV-2 Nucleocapsid in ELISA. Geeignet für SARS Coronavirus-2 (SARS-CoV-2).
SARS-CoV-2 N
Reaktivität: SARS Coronavirus-2 (SARS-CoV-2), SARS Coronavirus (SARS-CoV)
ELISA, IF, Neut
Wirt: Human
Monoclonal
CR3018 (03-018)
unconjugated
Recombinant Antibody
Applikationshinweise
ELISA: 1:5,000-1:10,000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Konzentration
1 mg/mL
Buffer
20 mM PB, 150 mM NaCl, pH 7.4
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20°C. Avoid freeze / thaw cycles.
Target
SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
Andere Bezeichnung
SARS-COV-2 NP
Hintergrund
Coronavirus NP,coronavirus Nucleocapsid,coronavirus Nucleoprotein,cov np,ncov NP,novel coronavirus NP,novel coronavirus Nucleocapsid,novel coronavirus Nucleoprotein,NP,Nucleocapsid,Nucleoprotein Antibody,Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. N protein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.